tadalafil has been researched along with brl 37344 in 2 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (brl 37344) | Trials (brl 37344) | Recent Studies (post-2010) (brl 37344) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 290 | 0 | 46 |
| Protein | Taxonomy | tadalafil (IC50) | brl 37344 (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 3 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 5 | |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.8697 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fonteles, MC; Gonzaga-Silva, LF; Linhares, BL; Marinho, LB; Moraes, MO; Nascimento, NRF; Reges, R; Santos, CF; Silva, APG | 1 |
| Barreira, MA; Carvalho, MF; Fechine, FVJ; Gonzaga-Silva, LF; Oliveira, RRM; Pamplona, TL | 1 |
2 other study(ies) available for tadalafil and brl 37344
| Article | Year |
|---|---|
Effect of co-administration of two different phosphodiesterase inhibitors and a β
Topics: Adrenergic beta-3 Receptor Agonists; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Ethanolamines; Humans; Male; Mice; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Rolipram; Tadalafil; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive | 2018 |
Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice1.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Ethanolamines; Male; Mice; NG-Nitroarginine Methyl Ester; Random Allocation; Tadalafil; Urinary Bladder, Overactive; Urination; Urological Agents | 2019 |